ArticleBreast cancer research and treatment2026

Impact of immune-related adverse events on response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: a single-institution retrospective study.

Michelle Sterpi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.